Saturday 17 October 2026
Export AMPH’s income statement to Excel — free account
Amphastar Pharmaceuticals, Inc.
AMPH Healthcare Drug Manufacturers Specialty & Generic
Amphastar Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.9 million, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 5.44%, EPS grew 4.55%, free cash flow grew 87.6% and total debt was flat, each against the same quarter a year earlier.
25.87
0.55
−2.08%
Follow AMPH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
12.75 | 11.29 | 21.93 | 15.08 | 17.92 | 502.75 | 18.55 | 0.00 | 249.61 | 77.08 |
Piotroski F-Score |
6 | 5 | 5 | 7 | 7 | 5 | 5 | 4 | 3 | 6 |
P/S ratio |
1.74 | 2.46 | 4.67 | 2.74 | 2.54 | 2.70 | 2.81 | 3.13 | 3.68 | 3.29 |
Altman Z-Score |
2.54 | 2.95 | 3.49 | 5.95 | 4.71 | 4.30 | 4.57 | 4.68 | 5.61 | 6.39 |
P/FCF ratio |
10.53 | 10.44 | 20.71 | 20.93 | 15.81 | 40.67 | 16,183.62 | 0.00 | 144.66 | 48.87 |
Altman Z″-Score (non-manufacturers) |
4.82 | 4.46 | 3.67 | 7.28 | 5.74 | 5.05 | 5.31 | 4.33 | 5.25 | 6.19 |
Beneish M-Score |
(2.57) | (2.44) | (2.12) | (2.31) | (2.58) | (2.58) | (2.53) | (2.72) | (2.35) | (3.03) |
P/Operating CF |
38.09 | 61.95 | 125.98 | 89.92 | 27.51 | 56.00 | 160.35 | 97.01 | 90.51 | 59.93 |
P/B ratio |
1.59 | 2.46 | 4.70 | 2.59 | 2.50 | 2.11 | 2.12 | 2.53 | 2.65 | 2.55 |
Price to Tangible BV |
5.62 | 12.70 | 115.07 | 2.79 | 2.74 | 2.32 | 2.35 | 2.87 | 3.06 | 3.01 |
EV/Sales |
2.19 | 2.97 | 5.18 | 2.54 | 2.40 | 2.52 | 2.68 | 2.99 | 3.58 | 3.15 |
EV/EBITDA |
7.87 | 8.23 | 13.54 | 9.54 | 11.25 | 27.18 | 47.81 | 111.51 | 59.05 | 26.71 |
EV/Operating CF |
10.10 | 10.20 | 18.19 | 14.21 | 10.72 | 15.41 | 20.69 | 23.05 | 21.90 | 20.82 |
EV/FCF |
13.27 | 12.64 | 22.99 | 19.37 | 14.93 | 37.95 | 15,426.84 | (221.59) | 140.53 | 46.74 |
Quick Ratio |
2.82 | 2.08 | 1.66 | 2.82 | 2.10 | 1.57 | 1.50 | 1.36 | 1.70 | 1.67 |
Current Ratio |
4.02 | 3.07 | 2.17 | 3.99 | 3.06 | 2.49 | 2.84 | 2.06 | 2.79 | 3.04 |
Net Debt/EBITDA |
1.62 | 1.43 | 1.34 | (0.77) | (0.67) | (1.95) | (2.35) | (5.46) | (1.73) | (1.22) |
Debt/Assets |
37.46% | 38.15% | 39.00% | 10.23% | 11.46% | 7.36% | 8.03% | 9.78% | 10.45% | 8.82% |
Debt/Equity |
0.77 | 0.82 | 0.92 | 0.14 | 0.17 | 0.10 | 0.11 | 0.14 | 0.14 | 0.11 |
Asset Turnover |
0.45 | 0.47 | 0.57 | 0.71 | 0.67 | 0.57 | 0.59 | 0.61 | 0.55 | 0.62 |
Operating CF/Net income |
1.59 | 1.34 | 1.33 | 0.98 | 1.58 | 40.82 | 0.85 | (6.66) | 10.75 | 3.93 |
Capex/Depreciation |
(0.62) | (0.70) | (0.77) | (0.94) | (1.17) | (1.57) | (2.29) | (2.55) | (2.09) | (1.46) |
Interest Coverage |
5.51 | 6.77 | 7.25 | 58.23 | 78.97 | 29.29 | (0.33) | (35.49) | (1.54) | 15.02 |
| 12.90% | 23.26% | 23.55% | 18.76% | 13.89% | 0.32% | 12.36% | (1.64%) | 1.10% | 3.14% | |
| 6.12% | 10.32% | 12.20% | 12.93% | 9.54% | 0.23% | 8.89% | (1.19%) | 0.83% | 2.40% | |
ROIC |
7.88% | 11.57% | 12.69% | 15.76% | 11.39% | 1.78% | (0.01%) | (1.68%) | (0.26%) | 3.28% |
Return on Tangible Assets |
12.44% | 24.26% | 25.15% | 17.52% | 13.55% | 0.33% | 12.26% | (1.77%) | 1.21% | 3.55% |
Average Days of Receivables |
81.49 | 68.83 | 65.40 | 65.08 | 65.81 | 69.27 | 51.73 | 64.67 | 63.88 | 38.33 |
Research and Development Expense of Revenue |
11.92% | 10.10% | 11.44% | 14.98% | 13.92% | 19.22% | 21.36% | 19.54% | 18.11% | 16.27% |
Selling, General and Administrative Expense of Revenue |
18.03% | 12.91% | 12.48% | 13.35% | 15.74% | 18.62% | 19.58% | 19.70% | 21.20% | 18.54% |
Intangible Assets out of Total Assets |
0.35 | 0.37 | 0.41 | 0.05 | 0.06 | 0.06 | 0.07 | 0.08 | 0.10 | 0.12 |
Share Based Compensation of Revenue |
3.79% | 3.33% | 3.14% | 3.58% | 4.27% | 5.86% | 5.37% | 5.66% | 7.11% | 5.93% |
Graham Net Nets |
(0.16) | (0.17) | (0.13) | 0.12 | 0.08 | 0.10 | 0.11 | 0.08 | 0.08 | 0.10 |
Graham Number |
28.24 | 33.46 | 29.10 | 21.40 | 16.52 | 2.93 | 14.59 | 0.00 | 3.54 | 6.26 |
Earnings Yield |
7.84% | 8.86% | 4.56% | 6.63% | 5.58% | 0.20% | 5.39% | (0.65%) | 0.40% | 1.30% |
Free Cash Flow Yield |
9.49% | 9.58% | 4.83% | 4.78% | 6.33% | 2.46% | 0.01% | (0.43%) | 0.69% | 2.05% |
Revenue per Share |
15.40 | 15.11 | 13.35 | 10.28 | 9.16 | 7.44 | 6.86 | 6.35 | 5.21 | 5.62 |
Operating CF per Share |
3.34 | 4.41 | 3.80 | 1.84 | 2.05 | 1.22 | 0.89 | 0.82 | 0.85 | 0.85 |
Capex per Share |
(0.79) | (0.85) | (0.79) | (0.49) | (0.57) | (0.72) | (0.88) | (0.91) | (0.72) | (0.47) |
Free Cash Flow per Share |
2.55 | 3.56 | 3.01 | 1.35 | 1.48 | 0.50 | 0.00 | (0.09) | 0.13 | 0.38 |
Cash per Share |
6.10 | 4.63 | 5.37 | 3.67 | 2.91 | 2.33 | 1.91 | 2.01 | 1.57 | 1.64 |
Shareholders Equity per Share |
16.88 | 15.12 | 13.25 | 10.89 | 9.33 | 9.54 | 9.10 | 7.85 | 7.24 | 7.26 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
16.88 | 15.12 | 13.25 | 10.89 | 9.33 | 9.54 | 9.10 | 7.85 | 7.24 | 7.26 |
Free Cash Flow |
118.98 | 172.35 | 145.34 | 65.57 | 70.54 | 23.41 | 0.21 | (3.97) | 6.11 | 17.18 |
Working Capital |
477.86 | 360.31 | 264.19 | 283.46 | 214.31 | 167.48 | 165.23 | 113.51 | 120.59 | 123.48 |
Capital Expenditures |
(37.13) | (41.04) | (38.17) | (23.61) | (27.46) | (33.85) | (41.55) | (42.16) | (33.10) | (21.38) |
Net Current Asset Value |
(204.48) | (311.10) | (383.89) | 164.99 | 92.11 | 97.17 | 95.80 | 71.14 | 70.44 | 85.61 |
EV/EBIT |
11.23 | 10.59 | 16.94 | 11.78 | 15.03 | 80.58 | 0.00 | 0.00 | 0.00 | 52.22 |
Capex to Sales |
0.05 | 0.06 | 0.06 | 0.05 | 0.06 | 0.10 | 0.13 | 0.14 | 0.14 | 0.08 |
Price to Operating Income |
8.92 | 8.75 | 15.26 | 12.74 | 15.92 | 86.36 | 0.00 | 0.00 | 0.00 | 54.59 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.20 | 0.17 | 0.11 | 0.10 | 0.08 | 0.08 | 0.08 | 0.09 | 0.10 |
Cash ROIC |
7.06% | 11.06% | 9.76% | 8.38% | 10.66% | 3.87% | 0.04% | (0.78%) | 1.35% | 3.89% |
Accounts Receivable Turnover |
4.82 | 5.77 | 6.30 | 5.94 | 6.02 | 6.24 | 6.59 | 6.25 | 6.98 | 8.47 |
Accounts Payable Turnover |
2.38 | 2.86 | 3.30 | 2.88 | 2.57 | 2.39 | 2.32 | 2.59 | 2.85 | 4.92 |
Inventory Turnover |
2.20 | 2.76 | 2.80 | 2.55 | 2.51 | 1.99 | 2.12 | 2.82 | 2.09 | 2.01 |
Average Days of Payables |
148.83 | 160.08 | 116.20 | 122.93 | 137.31 | 168.80 | 147.68 | 170.01 | 140.36 | 114.95 |
Days of Inventory on Hand |
177.46 | 156.70 | 131.72 | 151.16 | 142.31 | 171.15 | 211.79 | 134.82 | 155.13 | 192.82 |
Average Receivables |
149.38 | 126.75 | 102.22 | 83.95 | 72.66 | 56.04 | 48.95 | 47.12 | 34.42 | 30.14 |
Average Payables |
152.70 | 125.21 | 88.80 | 86.89 | 92.52 | 86.28 | 82.23 | 72.49 | 52.55 | 30.71 |
Average Inventory |
165.32 | 129.79 | 104.71 | 98.20 | 94.82 | 103.67 | 89.91 | 66.47 | 71.68 | 75.21 |
Average Assets |
1,603.38 | 1,545.19 | 1,127.45 | 706.76 | 651.38 | 609.10 | 550.27 | 482.32 | 439.41 | 408.94 |
Average Common Equity |
760.55 | 685.86 | 584.04 | 487.09 | 447.12 | 438.13 | 395.94 | 349.05 | 331.50 | 312.38 |
Columns are period end dates